The Evidence to Policy Initiative (E2Pi) is a global health policy collaboration between UCSF Global Health Group and SEEK Development. E2Pi conducts independent analysis and evidence synthesis to inform discussion and decision-making on critical policy and strategic issues in global health. 

The Affordable Medicines Facility-malaria (AMFm) is an innovative financing mechanism, managed by the Global Fund to Fight AIDS, Tuberculosis and Malaria, to increase the use of artemisinin-based combination therapies for treating malaria. To evaluate the AMFm pilot in eight countries, E2Pi conducted an analysis estimating predetermined “benchmarks” of success at 1 and 2 years.

The Evidence to Policy Initiative (E2Pi) is a global health policy collaboration between UCSF Global Health Group and SEEK Development. E2Pi conducts independent analysis and evidence synthesis to inform discussion and decision-making on critical policy and strategic issues in global health. 

The Evidence to Policy Initiative (E2Pi) is a global health policy collaboration between UCSF Global Health Group and SEEK Development. E2Pi conducts independent analysis and evidence synthesis to inform discussion and decision-making on critical policy and strategic issues in global health.